BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36972232)

  • 1. Serum Fibroblast Growth Factor-21 Discriminates Between Decompensated Alcohol-Associated Cirrhosis and Severe Alcohol-Associated Hepatitis.
    McLean Diaz P; Vannier A; Joshi AD; Mahle RE; Przybyszewski EM; Corey K; Chung RT; Luther J; Goodman RP; Schaefer EAK
    Clin Transl Gastroenterol; 2023 Jun; 14(6):e00585. PubMed ID: 36972232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis.
    Sehrawat TS; Arab JP; Liu M; Amrollahi P; Wan M; Fan J; Nakao Y; Pose E; Navarro-Corcuera A; Dasgupta D; Liao CY; He L; Mauer AS; Avitabile E; Ventura-Cots M; Bataller RA; Sanyal AJ; Chalasani NP; Heimbach JK; Watt KD; Gores GJ; Gines P; Kamath PS; Simonetto DA; Hu TY; Shah VH; Malhi H
    Hepatology; 2021 Feb; 73(2):571-585. PubMed ID: 32246544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis.
    Hanouneh IA; Zein NN; Cikach F; Dababneh L; Grove D; Alkhouri N; Lopez R; Dweik RA
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):516-23. PubMed ID: 24036050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis.
    Trépo E; Goossens N; Fujiwara N; Song WM; Colaprico A; Marot A; Spahr L; Demetter P; Sempoux C; Im GY; Saldarriaga J; Gustot T; Devière J; Thung SN; Minsart C; Sersté T; Bontempi G; Abdelrahman K; Henrion J; Degré D; Lucidi V; Rubbia-Brandt L; Nair VD; Moreno C; Deltenre P; Hoshida Y; Franchimont D
    Gastroenterology; 2018 Mar; 154(4):965-975. PubMed ID: 29158192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-11 drives human and mouse alcohol-related liver disease.
    Effenberger M; Widjaja AA; Grabherr F; Schaefer B; Grander C; Mayr L; Schwaerzler J; Enrich B; Moser P; Fink J; Pedrini A; Jaschke N; Kirchmair A; Pfister A; Hausmann B; Bale R; Putzer D; Zoller H; Schafer S; Pjevac P; Trajanoski Z; Oberhuber G; Adolph T; Cook S; Tilg H
    Gut; 2023 Jan; 72(1):168-179. PubMed ID: 35365572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease.
    Trépo E; Ouziel R; Pradat P; Momozawa Y; Quertinmont E; Gervy C; Gustot T; Degré D; Vercruysse V; Deltenre P; Verset L; Gulbis B; Franchimont D; Devière J; Lemmers A; Moreno C
    J Hepatol; 2013 Aug; 59(2):344-50. PubMed ID: 23557869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abstinence from alcohol and alcohol rehabilitation therapy in alcoholic liver disease: a population-based study.
    Björnsson ES; Hauksson K; Sigurdardottir R; Arnardottir M; Agustsson AS; Lund SH; Kalaitzakis E
    Scand J Gastroenterol; 2020 Apr; 55(4):472-478. PubMed ID: 32233877
    [No Abstract]   [Full Text] [Related]  

  • 8. ACG Clinical Guideline: Alcohol-Associated Liver Disease.
    Jophlin LL; Singal AK; Bataller R; Wong RJ; Sauer BG; Terrault NA; Shah VH
    Am J Gastroenterol; 2024 Jan; 119(1):30-54. PubMed ID: 38174913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical criteria accurately diagnose severe but not moderate alcohol-associated hepatitis: A systematic review and meta-analysis.
    Verma N; Mehtani R; Haiar JM; Pradhan P; Duseja A; Im GY; Singal AK
    Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38497934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol-associated liver disease: Epidemiology and management.
    Hernández-Évole H; Jiménez-Esquivel N; Pose E; Bataller R
    Ann Hepatol; 2024; 29(1):101162. PubMed ID: 37832648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope.
    Gala KS; Vatsalya V
    Cells; 2020 Feb; 9(3):. PubMed ID: 32106390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum interleukin 8 and 12 levels predict severity and mortality in patients with alcoholic hepatitis.
    Patel OP; Noor MT; Kumar R; Thakur BS
    Indian J Gastroenterol; 2015 May; 34(3):209-15. PubMed ID: 26108651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Algorithms to Identify Alcoholic Hepatitis Hospitalizations in Patients with Cirrhosis.
    Panchal SA; Kaplan DE; Goldberg DS; Mahmud N
    Dig Dis Sci; 2022 Sep; 67(9):4395-4402. PubMed ID: 35022905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis.
    Lee BP; Samur S; Dalgic OO; Bethea ED; Lucey MR; Weinberg E; Hsu C; Rinella ME; Im GY; Fix OK; Therapondos G; Han H; Victor DW; Voigt MD; Eswaran S; Terrault NA; Chhatwal J
    Gastroenterology; 2019 Aug; 157(2):472-480.e5. PubMed ID: 30998988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients.
    Sandahl TD; Støy SH; Laursen TL; Rødgaard-Hansen S; Møller HJ; Møller S; Vilstrup H; Grønbæk H
    PLoS One; 2017; 12(12):e0189345. PubMed ID: 29236785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcoholic Foamy Degeneration, an Entity Resembling Alcohol-Associated Hepatitis: Diagnosis, Prognosis, and Molecular Profiling.
    Gratacós-Ginès J; Avitabile E; Montironi C; Guillamon-Thiery A; Hernández-Évole H; Moreta MJ; Blaya D; Ariño S; Rubio AB; Pérez-Guasch M; Cervera M; Carol M; Fabrellas N; Soria A; Juanola A; Graupera I; Sancho-Bru P; Díaz A; Coll M; Bataller R; Ginès P; Pose E
    Clin Gastroenterol Hepatol; 2024 Apr; 22(4):768-777.e8. PubMed ID: 38065374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal Virome in Patients With Alcoholic Hepatitis.
    Jiang L; Lang S; Duan Y; Zhang X; Gao B; Chopyk J; Schwanemann LK; Ventura-Cots M; Bataller R; Bosques-Padilla F; Verna EC; Abraldes JG; Brown RS; Vargas V; Altamirano J; Caballería J; Shawcross DL; Ho SB; Louvet A; Lucey MR; Mathurin P; Garcia-Tsao G; Kisseleva T; Brenner DA; Tu XM; Stärkel P; Pride D; Fouts DE; Schnabl B
    Hepatology; 2020 Dec; 72(6):2182-2196. PubMed ID: 32654263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of the Alcoholic Hepatitis Histologic Score in Korean Patients with Biopsy-Proven Alcoholic Hepatitis.
    Lee DH; Choi YI; Bae JM; Chang MS; Joo SK; Jung YJ; Lee KL; Kim BG; Kim W
    Gut Liver; 2020 Sep; 14(5):636-643. PubMed ID: 32457277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-month assessment of Th-cell axis related inflammatory cytokines, IL-17 and IL-22 and their role in alcohol-associated liver disease.
    Sagaram M; Frimodig J; Jayanty D; Hu H; Royer AJ; Bruner R; Kong M; Schwandt ML; Vatsalya V
    Front Immunol; 2023; 14():1202267. PubMed ID: 38162671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating concentrations of interleukin-18, interleukin-18 binding protein, and gamma interferon in patients with alcoholic hepatitis.
    Spahr L; Garcia I; Bresson-Hadni S; Rubbia-Brandt L; Guler R; Olleros M; Chvatchko Y; Hadengue A
    Liver Int; 2004 Dec; 24(6):582-7. PubMed ID: 15566508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.